Potassium citrate vs. hydrochlorothiazide to reduce urinary calcium excretion in calcium oxalate stone patients with hypercalciuria: a prospective randomized study
- 26 April 2021
- journal article
- research article
- Published by Springer Nature in International Urology and Nephrology
- Vol. 53 (9) , 1791-1796
Abstract
Purpose Calcium oxalate (Ca-Ox) is the most common stone composition and one of the most common 24-h urine anomalies is hypercalciuria. The purpose of this study was to evaluate the efficacy of potassium citrate (K-CIT) for prevention of hypercalciuria in comparison with hydrochlorothiazide (HCT) in patients with calcium oxalate stones and hypercalciuria. Materials and methods In this prospective randomized study, patients were randomized to receive either HCT (50 mg/day) or K-CIT (40 mEq/day) following achieving stone-free status. Treatment was continued for 6 months. 24 h urine analysis was performed prior to treatment and repeated at third month and measured parameters were volume, calcium, oxalate, citrate, sodium, and uric acid. Stone recurrence was evaluated with KUB and ultrasonography at 6th and 12th months. Results Data of 40 patients in each arm were evaluated. Mean 24 h urine calcium levels decreased to 205 ± 54.5 mg/day and 220.6 ± 96.3 mg/day in the K-CIT and HCT groups, respectively, and difference was not significant (p = 0.931). The reduction compared to pretreatment values was statistically significant in both groups. Urinary citrate levels also significantly increased in both groups and level of increase was significantly higher in K-CIT group. At 12th month, ultrasonography revealed stones in two patients in HCT group, and in one patient in the K-CIT group. Conclusions K-CIT provided significantly reduced calcium and increased citrate excretion in patients Ca-Ox stone patients with hypercalciuria. The efficacy in decreasing calcium excretion was comparable to HCT treatment. K-CIT can be used for medical prophylaxis of Ca-OX stone patients with hypercalciuria.Keywords
This publication has 20 references indexed in Scilit:
- Trends in urological stone diseaseBJU International, 2011
- Impact of Long-Term Potassium Citrate Therapy on Urinary Profiles and Recurrent Stone FormationJournal of Urology, 2009
- Adverse Metabolic Side Effects of Thiazides: Implications for Patients With Calcium NephrolithiasisJournal of Urology, 2007
- Acid-Base Status Determines the Renal Expression of Ca2+ and Mg2+ Transport ProteinsJournal of the American Society of Nephrology, 2006
- Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic HypercalciuriaNew England Journal of Medicine, 2002
- A prospective study of nonmedical prophylaxis after a first kidney stoneBJU International, 1999
- Urinary tamm-horsfall protein increased after potassium citrate therapy in calcium stone formersUrology, 1995
- Ambulatory evaluation of nephrolithiasis: An update of a 1980 protocolThe American Journal of Medicine, 1995
- Thiazide Treatment for Calcium Urolithiasis in Patients with Idiopathic HypercalciuriaBritish Journal of Urology, 1992
- Thiazides in the prophylactic treatment of recurrent idiopathic kidney stonesInternational Urology and Nephrology, 1986